Tizanidine
- Product NDC
- 0615-8360
- 11-digit product format
- 006158360
- Labeler code
- 0615
- Product ID
- 0615-8360_2b5b4332-181d-436d-9796-4ff40231a5cc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA076416
- Marketing category
- ANDA
- Marketing start
- 2003-12-11
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0615-8360-39 | 00615836039 | 30 TABLET in 1 BLISTER PACK (0615-8360-39) | 30 tablet | 2020-10-08 | 0000-00-00 | No | No | Current |